MENU
+Compare
MGNX
Stock ticker: NASDAQ
AS OF
Jul 18 closing price
Price
$1.48
Change
-$0.06 (-3.90%)
Capitalization
93.37M

MGNX MacroGenics Forecast, Technical & Fundamental Analysis

Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer... Show more

Industry: #Biotechnology
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MGNX with price predictions
Jul 18, 2025

MGNX in upward trend: 10-day moving average broke above 50-day moving average on July 16, 2025

The 10-day moving average for MGNX crossed bullishly above the 50-day moving average on July 16, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MGNX's RSI Oscillator exited the oversold zone, of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on July 08, 2025. You may want to consider a long position or call options on MGNX as a result. In of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MGNX just turned positive on July 03, 2025. Looking at past instances where MGNX's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MGNX advanced for three days, in of 270 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 55 cases where MGNX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

MGNX moved below its 50-day moving average on July 18, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MGNX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MGNX broke above its upper Bollinger Band on July 09, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. MGNX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.180) is normal, around the industry mean (18.109). P/E Ratio (0.000) is within average values for comparable stocks, (58.647). MGNX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.460). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.610) is also within normal values, averaging (270.773).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MGNX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

MGNX is expected to report earnings to fall 28.57% to -46 cents per share on August 12

MacroGenics MGNX Stock Earnings Reports
Q2'25
Est.
$-0.46
Q1'25
Est.
$-0.65
Q4'24
Beat
by $0.16
Q3'24
Beat
by $0.69
Q2'24
Missed
by $0.23
The last earnings report on May 13 showed earnings per share of -64 cents, meeting the estimate of -64 cents. With 381.88K shares outstanding, the current market capitalization sits at 93.37M.
A.I. Advisor
published General Information

General Information

a company, which engages in the discovery and development of monoclonal antibody-based therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
9704 Medical Center Drive
Phone
+1 301 251-5172
Employees
339
Web
https://www.macrogenics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZCTSF0.04N/A
+6.78%
Zacatecas Silver Corp.
SYANY12.99N/A
N/A
Sydbank A/S
CLLKF3.55N/A
N/A
BICO GROUP AB
PLQC60.00N/A
N/A
Plains Acquisition Corp.
SGIOY8.35-0.09
-1.07%
Shionogi & Co. Ltd.

MGNX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MGNX has been loosely correlated with XNCR. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MGNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGNX
1D Price
Change %
MGNX100%
-3.90%
XNCR - MGNX
51%
Loosely correlated
-1.10%
CRBU - MGNX
51%
Loosely correlated
+12.02%
CRSP - MGNX
48%
Loosely correlated
+18.22%
BEAM - MGNX
48%
Loosely correlated
+1.47%
SYRE - MGNX
47%
Loosely correlated
-3.55%
More